Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF
Por um escritor misterioso
Descrição
Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF hamster model at the Keystone conference
Differential Pathophysiological Mechanisms in Heart Failure With a
Liraglutide shows superior cardiometabolic benefits than
Cellular and molecular pathobiology of heart failure with
Immunometabolic mechanisms of heart failure with preserved
Frontiers A potential role of autophagy-mediated vascular
Pathophysiological mechanisms of heart failure with preserved
Cardiometabolic HFpEF: NASH of the Heart
Heart Failure with Preserved Ejection Fraction and Obstructive
Immunometabolic mechanisms of heart failure with preserved
Frontiers Rationale for the Use of Pirfenidone in Heart Failure
Improving insights into the heterogeneous HFpEF syndrome through
Full article: Heart failure with preserved ejection fraction
François Briand en LinkedIn: #ksns #nash #obesity #drugdevelopment
de
por adulto (o preço varia de acordo com o tamanho do grupo)
